Corrigendum to "Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-κB and AP-1 mediated transcription activation and as potential anti-inflammatory agents" [Eur J Med Chem 44 (2009) 2184-2189] (DOI:10.1016/j.ejmech.2008.10.031)

European Journal of Medicinal Chemistry

Volumn 44, Issue 11, 2009, Pages 4783-

  Giri, Rajan S ^a   Thaker, Hardik M ^b   Giordano, Tony ^c   Williams, Jill ^c   Rogers, Donna ^c   Sudersanam, Vasudevan ^b   Vasu, Kamala K ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b B V PATEL PHARMACEUTICAL EDUCATION AND RESEARCH DEVELOPMENT PERD CENTRE   (India)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR;

EID: 70349967897     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.04.024     Document Type: Erratum

References (0)